Thanks so much for your research and feedback!!

Lynda

---------------
Hi,

Epstein Barr can be activated by the Covid vac. In some cases, the Epstein Barr virus (or reactivation of a dormant EB virus) can cause paralysis, muscle spasm's and more.

Please don't share my name or email.

------------
The patient was finally diagnosed with infectious mononucleosis caused by primary EBV infection. His initial symptoms of fever and sore throat gradually improved by only conservative treatment; therefore, he was supposed to be discharged from the hospital. However, on day 7, he complained about neurologic symptoms of numbness and paresthesia localized to hands and feet bilaterally. Neurologic symptoms progressed gradually into bilateral upper and lower extremities. The motor power of his extremities was estimated as grade 4, and deep tendon reflexes were decreased bilaterally 1+. Therefore, lumbar puncture was performed. The findings of the cerebrospinal fluid (CSF) analysis were a leukocyte count of 4 cells/mm3, erythrocyte count of 0 cells/mm3, glucose concentration of 55 mg/dL, and protein levels of 102 mg/dL, suggesting albuminocytologic dissociation. Brain magnetic resonance imaging was normal.

The patient was diagnosed with GBS, based on clinical symptoms and CSF analysis. A nerve conduction study showed prolonged terminal latency, delayed F-wave response, and decreased compound muscle action potential and sensory nerve action potential in the bilateral extremities. This was a pattern consistent with sensor-motor polyneuropathy. Although the patient was considered for treatment with intravenous immunoglobulin and plasmapheresis, his vital signs (assessed through respiratory and cardiac monitoring) were stable, and progressive motor weakness (estimated grade 3 to 4) of the limbs did not develop. After only conservative treatments, the patient fully regained motor and sensory functions without sequelae. He was discharged from hospital on day 40.

This report illustrates a case of a young adult with infectious mononucleosis caused by primary EBV infection who developed GBS with neurologic complications, but did not progress to a severe course (with quadriplegia or respiratory failure) of the disease.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094921/
-----------

snip:

Two recently published studies available on the National Institutes of Health (NIH) website indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases.

The first evidence linking EBV reactivation to long COVID symptoms was discovered by Gold et al. (2021) and published in Pathogens. This study can be viewed on the NIH website here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233978/

We ran Epstein-Barr virus serological tests on COVID-19 patients at least 90 days after testing positive for SARS-CoV-2 infection, comparing EBV reactivation rates of those with long COVID symptoms to those who never experienced long COVID symptoms. We found over 73% of COVID-19 patients who were experiencing long Covid symptoms were also positive for EBV reactivation."

Jeffrey E. Gold, Lead Study Author, World Organization

Another group of researchers, Chen et al. (2021), found EBV reactivation may also be associated with COVID-19 severity. Their report published in Scientific Reports by Nature is available here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149409/

According to Gold, more than 95% of health adults will test positive for latent EBV infection, identified by testing for the presence of EBV VCA IgG and/or EBV nuclear antigen 1 (EBNA-1) IgG. EBV reactivation, on the other hand, is identified by further testing for the presence of EBV EA-D IgG, EBV VCA IgM, and/or circulating EBV DNA.

David J. Hurley, PhD, a professor and molecular microbiologist at the University of Georgia and coauthor of the Pathogens study said, "We found similar rates of EBV reactivation in those who had long COVID symptoms for months, as in those with long COVID symptoms that began just weeks after testing positive for COVID-19. This indicated to us that EBV reactivation likely occurs simultaneously or soon after COVID-19 infection."

According to Gold, other diseases and stressors can also trigger EBV reactivation, this is not exclusive to COVID-19. The inflammation response from SARS-CoV-2 infection, however, appears more successful than many other stressors at triggering EBV reactivation. While EBV reactivation may not be responsible for all cases of recurring fatigue or brain fog after recovering from COVID-19, evidence indicates that it likely plays a role in many or even most cases.
more:
https://www.news-medical.net/news/20210722/Epstein-Barr-virus-reactivation-may-play-a-role-in-long-COVID-and-severe-COVID-19-cases.aspx